r3 stem cell Tag

The implementation of technology in healthcare has led to the development of novel treatment methods for addressing injuries and medical conditions that were once limited to the invasive nature of surgeries and the side effects of pharmaceutical drugs. One such innovative development is stem cells.Stem...

Light chain amyloidosis results from clonal plasma cells; however, cell therapy directed against these clone cells has remained the most effective treatment for the condition. Over time, autologous stem cell transplantation (ASCT) has become a critical treatment resource for addressing light-chain amyloidosis.Following ASCT, patients with...

R3 Stem Cell and Founder Dr. David Greene have been featured in the Cover story for 10 Best Healthcare Companies to Watch in 2022 by Silicon Review Magazine. After a decade of providing first-rate regenerative therapies, R3 has become the global leader for patients desiring safe, effective...